Ibogaine, a psychoactive indole alkaloid derived from the root bark of the African shrub Tabernanthe iboga, has emerged as a potential therapeutic agent for TBI.

Trauma significantly alters brain structure, leading to PTSD symptoms like hypervigilance, intrusive thoughts, and memory issues, but targeted therapies can help survivors heal and regain control.

The new drug has already passed Phase 1 safety trials in humans, making it a "strong candidate" for future PTSD treatments.

New functional imaging studies show that the brain function of patients with PTSD plus major depression is very different from that of patients with PTSD alone and should be treated accordingly.

The diagnosis of posttraumatic stress disorder (PTSD) has undergone much more than a minor tweaking or superficial facelift in the American Psychiatric Association's DSM-5. This guidebook to ...

Trauma doesn’t always end when the danger is over. For many, the body and brain remain locked in survival mode, long after the traumatic event has passed. This is the painful reality of post-traumatic ...

A University of Alabama at Birmingham expert unpacks the complexities of PTSD, its impact on the brain and sleep, and how individuals can navigate emotional and cognitive challenges through treatment.

Traumatic brain injuries can have lasting effects on memory, mood, and aging. Explore what causes these issues—and how they’re treated.

The trauma associated with TBI can lead to changes in the function and/or structure of the brain, which, in turn, contributes to neuropsychiatric symptoms.

Trauma, if untreated, can be life debilitating. There's little use in will power if flashbacks make you unable to leave your ...